Human medicines

Gastrografin

Recall | Medicines | 09/03/2012

The marketing authorization holder has informed its supplied customers in a letter dated March 2, 2012, that the packages of the batches listed above…

Gastrografin Read more

BufloMed

Recall | Medicines | 02/03/2012
BufloMed Read more

Kottas Kidney Bladder Tea

Replacement | Medicines | 01/03/2012

The marketing authorization holder informed its supplied customers by letter dated 01.03.2012 that the above batch was mistakenly delivered in sachets…

Kottas Kidney Bladder Tea Read more

Nutriflex

Recall | Medicines | 01/02/2012

The marketing authorization holder has informed its supplied customers in a letter dated 26.01.2012 that crystalline particles may be present in the…

Nutriflex Read more

Nutriflex

Recall | Medicines | 22/12/2011

The marketing authorization holder has informed its supplied customers in a letter dated December 21, 2011, that crystalline particles may be present…

Nutriflex Read more

Velcade

Recall | Medicines | 22/12/2011

In a letter dated December 12, 2011, the distribution partner informed the institutional pharmacies supplied that the marketing authorization holder…

Velcade Read more

Vistide

Replacement | Medicines | 14/12/2011

The marketing authorization holder has informed its supplied customers by letter dated 14.12.2011 that the above mentioned batches have to be recalled…

Vistide Read more

Velcade

Recall | Medicines | 28/11/2011

The marketing authorization holder has informed the supplied customers by letter dated November 28, 2011, that a GMP inspection of the manufacturer…

Velcade Read more

Busilvex

Replacement | Medicines | 25/11/2011

The distributor has informed the supplied institutional pharmacies in a letter dated November 25, 2011, that a GMP inspection of the manufacturer Ben…

Busilvex Read more

Enapril

Replacement | Medicines | 16/11/2011

The marketing authorization holder informed its supplied customers in a letter dated November 14, 2011, that there was misinformation in the…

Enapril Read more
Email

Further inquiry note